Pharma industry insights and updates

The Hidden Cost of a Bad Pharma Portfolio Decision

What is the true financial impact of an incorrect pharmaceutical product selection? This strategic B2B guide analyzes the "Portfolio Iceberg," breaks down invisible opportunity costs, and demonstrates how pharma executives use Pipelinepharma's live pipeline intelligence to prevent margin erosion.

Drug Pipeline Intelligence: What It Is and How Pharma Companies Use It

What is drug pipeline intelligence, and how do pharma companies use it to optimize capital allocation? This comprehensive B2B guide explains how to map the unlaunched product layer, bridge regulatory time lags, align cross-functional teams, and leverage AI-driven portfolio analysis via Pipelinepharma.

How to Analyze Generic Drug Competition Before You Invest

How can pharma C-level executives stress-test capital allocations before investing in generic assets? This strategic B2B guide delivers an operational framework to calculate dossier density, map unlaunched pre-launch pipelines, forecast price erosion, and identify Blue Ocean portfolio opportunities via Pipelinepharma.

Pharmaceutical Dossiers for Sale: How to Buy a CTD Dossier

How can corporate pharma teams execute systematic asset acquisitions and buy CTD dossiers? This definitive B2B guide delivers an operational framework to evaluate international IP rights, conduct technical eCTD due diligence, manage technology transfers, and source active marketing authorizations via Pipelinepharma.

CTD Dossiers for Licensing: Where to Find Them and What to Check

How can pharma portfolio managers source and audit compliant CTD dossiers for international licensing? This definitive B2B guide delivers a practical framework to evaluate technical completeness, compare "Ready-to-File" versus "Under Development" assets, and run parallel outreach via Pipelinepharma.

How to Find Pharmaceutical Distributors in New Markets

How can FDF manufacturers secure the right international pharmaceutical distributors? This systematic B2B guide delivers an operational framework to map sales channels, manage marketing authorization ownership, audit portfolio conflicts, and negotiate binding distribution agreements via Pipelinepharma.

Pharmaceutical Sourcing: How to Find Generic Drug Manufacturers

How can pharma procurement teams optimize generic drug manufacturing discovery? This step-by-step B2B guide delivers a structured framework to find, evaluate, and secure generic drug manufacturers—helping you separate API sourcing from FDF procurement and de-risk your supply chain via Pipelinepharma.

How to Find International Buyers for Your Pharmaceutical Products

How can FDF manufacturers and CTD dossier owners find qualified international pharmaceutical buyers? This comprehensive B2B guide delivers a systematic framework to screen overseas distributors, enforce strict pre-qualification, protect pipeline anonymity, and accelerate out-licensing deal velocity via Pipelinepharma.

Pharmaceutical Supply Agreements: A Practical Guide for Buyers and Manufacturers

How should pharma B2B teams structure and negotiate commercial supply contracts? This operational guide delivers a practical framework for buyers and manufacturers, covering regulatory splits, rolling forecasts, standalone Quality Agreements, and risk-mitigation strategies via Pipelinepharma.

Pharmaceutical Licensing: How to Find the Right Licensing Partner

How can pharma BD executives optimize international out-licensing and in-licensing deals? This comprehensive B2B guide outlines a strategic framework to find, vet, and select pharmaceutical licensing partners—helping you bypass brokers, maintain pre-deal anonymity, and accelerate deal velocity using Pipelinepharma.